Literature DB >> 9058657

Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis.

C Ramos-Remus1, A Gomez-Vargas, A Hernandez-Chavez, J I Gamez-Nava, L Gonzalez-Lopez, A S Russell.   

Abstract

OBJECTIVE: To describe the clinical and radiological 2-yr followup of 22 patients with anterior atlantoaxial subluxation (AAS) from a prospective cohort of patients with ankylosing spondylitis.
METHODS: The 2-yr assessment included a structured questionnaire for rheumatologic and neurologic complaints and lateral cervical radiographs in maximal flexion view. Initial and 2-yr radiographs were assessed blind to patient data. The course of anterior AAS was classified as unchanged (< 1 mm), progression (> or = 1 mm) or regression (> or = 1 mm) at 2 yrs compared with baseline. Vertical AAS was classified using the Sakaguchi-Kauppi method. Magnification factor was corrected using the ratio of C3 width.
RESULTS: Anterior AAS was detected in 22 patients at baseline examination. Two patients also had vertical AAS; 86% were male. Mean age was 33 +/- 9 yrs and mean disease duration was 12 +/- 7 yrs. At followup, one patient had died of acquired immunodeficiency syndrome, 3 could not be reached, and 2 had undergone surgical fusion due to severe myelopathy and now showed complete neurological recovery. Of the remaining 16 patients, 7 (32%) showed progression and 9 (41%) showed no change in the C1-odontoid distance. Vertical AAS developed in one patient. After the 2-yr assessment, 3 additional patients had surgical fusion because of notable progression of AAS, despite absence of neurological signs.
CONCLUSION: Anterior AAS progressed in a number of these patients in the 2 yrs following its detection, and with or without neurological signs, surgical management was thought appropriate in a considerable number of them.

Entities:  

Mesh:

Year:  1997        PMID: 9058657

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Conventional treatments for ankylosing spondylitis.

Authors:  M Dougados; B Dijkmans; M Khan; W Maksymowych; Sj van der Linden; J Brandt
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

2.  Odontoid pannus formation in a patient with ankylosing spondylitis causing atlanto-axial instability.

Authors:  Rizwan Rajak; Phil Wardle; Ceril Rhys-Dillon; James C Martin
Journal:  BMJ Case Rep       Date:  2012-02-25

Review 3.  Beyond the joints: neurological involvement in rheumatoid arthritis.

Authors:  Cesar Ramos-Remus; Sergio Duran-Barragan; Jose Dionisio Castillo-Ortiz
Journal:  Clin Rheumatol       Date:  2011-09-20       Impact factor: 2.980

Review 4.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 5.  The emergency room in systemic rheumatic diseases.

Authors:  G Slobodin; A Hussein; M Rozenbaum; I Rosner
Journal:  Emerg Med J       Date:  2006-09       Impact factor: 2.740

6.  Symptomatic improvement in function and disease activity in a patient with ankylosing spondylitis utilizing a course of chiropractic therapy: a prospective case study.

Authors:  Susan M Rutherford; Cameron F Nicolson; Edward R Crowther
Journal:  J Can Chiropr Assoc       Date:  2005-06

7.  Instantaneous death risk, conditional survival and optimal surgery timing in cervical fracture patients with ankylosing spondylitis: A national multicentre retrospective study.

Authors:  Jinfeng Huang; Hao Bai; Quanchang Tan; Dingjun Hao; Aimin Wu; Qingde Wang; Bing Wang; Linfeng Wang; Hao Liu; Xiongsheng Chen; Zhengsong Jiang; Xiaoming Ma; Xinyu Liu; Peng Liu; Weihua Cai; Ming Lu; Ningfang Mao; Yong Wang; Suochao Fu; Shuai Zhao; Xiaofang Zang; Youzhuan Xie; Haiyang Yu; Ruixian Song; Jiangbo Sun; Liangbi Xiang; Xiang Liu; Songkai Li; Bo Liao; Zixiang Wu
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

8.  Treatment of ankylosing spondylitis: focus on etanercept.

Authors:  Tracy Frech
Journal:  Biologics       Date:  2007-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.